Extracts from the press conference by Joaquín Almunia on Antitrust decisions in the pharmaceutical sector
On 25 July 2012, Joaquín Almunia, Vice-President of the EC in charge of Competition, gave a press conference at the European Commission in Brussels.
On this occasion, he announced that, following a competition inquiry into the pharmaceutical sector of 2008/2009, the European Commission has issued a statement of objections against Lundbeck and other pharmaceutical companies in a major investigation concerning an antidepressant.
At the same time, the European Commission's third report on its monitoring of patent settlements in the pharmaceutical sector confirmed that, while the overall number of concluded settlements has significantly increased, the proportion of settlements that may be problematic for competition has fallen by half as compared to the levels observed at the time of the sector inquiry. SHOTLIST